Updated Jun. 24, 2013 at 10:46 a.m.

Premium Lock Potential GSK diabetes drug shows mixed results in studies

Published: 2013-06-24 06:23:00
Updated: 2013-06-24 10:46:07

Diabetes   Diabetes

Albiglutide's once-weekly dosing would make the drug more convenient for patients compared with existing once-daily treatments. Still, it will face challenges as it enters a "crowded area," Patrick Vallance, Glaxo's head of pharmaceuticals research and development, says....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders